<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choice of initial antiviral therapy in infants with virologically confirmed congenital cytomegalovirus infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet"/></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choice of initial antiviral therapy in infants with virologically confirmed congenital cytomegalovirus infection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Choice of initial antiviral therapy in infants with virologically confirmed congenital cytomegalovirus infection</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2"> </td> <td class="subtitle1" colspan="3">Suggested initial antiviral agent</td> </tr> <tr> <td class="subtitle2">Ganciclovir*</td> <td class="subtitle2">Valganciclovir<sup>¶</sup></td> <td class="subtitle2">Antiviral therapy <strong>not</strong> indicated</td> </tr> <tr> <td>CMV-specific symptoms</td> <td> <p><strong>Life-threatening symptoms</strong></p> <strong>Any</strong> of the following: <ul class="decimal_heading"> <li>Viral sepsis-like syndrome </li> <li>Pneumonitis </li> <li>Myocarditis </li> <li>Severe hepatitis </li> <li>Enterocolitis </li> <li>Severe and refractory thrombocytopenia </li> <li>Sight-threatening retinitis </li> </ul> </td> <td> <p><strong>Non-life-threatening symptoms</strong></p> <p>Examples include: </p> <ul> <li>Microcephaly or intracranial calcifications without seizures or encephalopathy</li> <li>Jaundice or hepatosplenomegaly without severe hepatitis or refractory thrombocytopenia</li> <li>Isolated hearing loss<sup>Δ</sup></li> </ul> <p><sup></sup> </p> <p><strong>Severe symptoms</strong></p> Infants with 1 or more of the conditions listed to the left may be candidates for oral valganciclovir if they meet all of the general medical condition criteria listed below</td> <td><strong>Asymptomatic</strong> (including passed newborn hearing screen)</td> </tr> <tr> <td>General medical condition</td> <td><strong>Any</strong> of the following: <ul class="decimal_heading"> <li>Seriously or critically ill, requiring NICU care </li> <li>Requiring mechanical ventilation, CPAP, or supplemental oxygen </li> <li>NPO </li> <li>Unable to tolerate oral feeds </li> <li>Malabsorption </li> </ul> </td> <td><strong>All</strong> of the following: <ul class="decimal_heading"> <li>Well appearing or mildly ill, being managed in newborn unit or at home </li> <li>On room air or low supplemental oxygen </li> <li>Able to tolerate oral feeds </li> <li>Stable and gaining weight </li> </ul> </td> <td>Stable and well appearing</td> </tr> <tr> <td>Immune status</td> <td>Primary immunodeficiency (eg, SCID)</td> <td>Immunocompetent</td> <td>Immunocompetent</td> </tr> </tbody></table></div><div class="graphic_footnotes">CMV: cytomegalovirus; NICU: neonatal intensive care unit; CPAP: continuous positive airway pressure; NPO: nothing by mouth; SCID: severe combined immunodeficiency; IV: intravenous.<br/>* Ganciclovir dosing is 6 mg/kg per dose administered IV every 12 hours. Treatment with IV ganciclovir should be for a maximum of 6 weeks. <font color="blue"><font color="black">Ganciclovir is dependent on renal function for clearance. The dose listed is for infant swith normal renal function</font></font><font color="black">. Infants initially treated with IV ganciclovir may transition to oral valganciclovir when their condition improves and oral feedings are tolerated.<br/>¶ Valganciclovir dosing is 16 mg/kg per dose of commercially available suspension administered orally every 12 hours. Treatment with oral valganciclovir should be continued for a total of 6 months for most newborns with symptomatic congenital CMV infection. The dose listed is for infants with normal renal function.</font><br/>Δ Evidence is lacking and expert opinion varies as to whether the benefits of antiviral therapy outweigh the risks in infants with isolated hearing loss.</div><div class="graphic_reference">References: 

<ol>
<li>Harrison GJ. Cytomegalovirus. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 7th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2014. p.1969.</li>
<li>Kimberlin DW, Lin CY, Sánchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143:16.</li>
<li>Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372:933.</li></ol></div><div id="graphicVersion">Graphic 100099 Version 3.0</div></div></div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
